1
|
Long E, You D, Wang S, Lu S, Xu P, Zhou J, Li L, Wu J, Zhang B, Zhu G, Lang J. Outcome of primary intraosseous carcinoma: cases review of a single institution. Oral Dis 2022. [PMID: 35500146 DOI: 10.1111/odi.14233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2022] [Revised: 04/17/2022] [Accepted: 04/27/2022] [Indexed: 02/05/2023]
Abstract
OBJECTIVE The purpose of this study was to investigate the prognostic factors and treatment of primary intraosseous carcinoma. METHODS Patients diagnosed with primary intraosseous carcinoma and received treatment in Sichuan cancer hospital from 2000 to 2019 were followed up and retrospectively reviewed. RESULTS A total of 28 patients were included in the study, with a mean age of 60 years (60±10.11). The 2-year and 5-year overall survival were 60.7% and 38.5% respectively. In the univariate analysis, surgery combined with adjuvant therapy improved the overall survival compared with surgery or radiotherapy alone (P=0.035), and patients received postoperative adjuvant radiotherapy had a higher overall survival than those who received radical radiotherapy (P = 0.01). In addition, patients with well differentiated tumors have increased progression free survival (P=0.01). Multivariate analyses showed that radiotherapy was an independent indicator for overall survival (P = 0.007). CONCLUSIONS surgery combined with adjuvant therapy is the superior treatment strategy for primary intraosseous carcinoma at present. This study is the first to confirm the positive role of radiotherapy in treating primary intraosseous carcinoma with data to back it up.
Collapse
Affiliation(s)
- En Long
- Department of Oncology, Southwest Medical University, 646000, Luzhou, China
| | - Dongling You
- Department of Oncology, Southwest Medical University, 646000, Luzhou, China
| | - Shubin Wang
- School of Medicine, University of Electronic Science and Technology of China, 610041, Chengdu, China
| | - Shun Lu
- Department of radiation oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Prevention and Control Center, School of Medicine, University of Electronic Science and Technology of China, 610041, Chengdu, China.,Department of Radiological Protection, Radiation Oncology Key Laboratory of Sichuan Province, 610041, Chengdu, China
| | - Peng Xu
- Department of radiation oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Prevention and Control Center, School of Medicine, University of Electronic Science and Technology of China, 610041, Chengdu, China
| | - Jie Zhou
- Department of radiation oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Prevention and Control Center, School of Medicine, University of Electronic Science and Technology of China, 610041, Chengdu, China
| | - Lu Li
- Department of radiation oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Prevention and Control Center, School of Medicine, University of Electronic Science and Technology of China, 610041, Chengdu, China
| | - Jian Wu
- Department of Oncology, Southwest Medical University, 646000, Luzhou, China
| | - Biqin Zhang
- School of Medicine, University of Electronic Science and Technology of China, 610041, Chengdu, China
| | - Guiquan Zhu
- Department of Head and Neck Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Prevention and Control Center, School of Medicine, University of Electronic Science and Technology of China, 610041, Chengdu, China.,State Key Laboratory of Oral Diseases, National Clinical Research Centre for Oral Diseases, Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, 610041, Chengdu, China
| | - Jinyi Lang
- Department of Oncology, Southwest Medical University, 646000, Luzhou, China.,Department of radiation oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Prevention and Control Center, School of Medicine, University of Electronic Science and Technology of China, 610041, Chengdu, China.,Department of Radiological Protection, Radiation Oncology Key Laboratory of Sichuan Province, 610041, Chengdu, China
| |
Collapse
|
2
|
Pavlin D, Dolenšek T, Švara T, Nemec A. Solid type primary intraosseous squamous cell carcinoma in a cat. BMC Vet Res 2018; 14:23. [PMID: 29357860 PMCID: PMC5778816 DOI: 10.1186/s12917-018-1344-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2017] [Accepted: 01/11/2018] [Indexed: 11/11/2022] Open
Abstract
Background Squamous cell carcinoma (SCC) is the most common nonodontogenic oral tumor in cats. In the jaw, it usually presents as an ulceroproliferative lesion associated with enlargement of the affected bone. Case presentation This report describes the case of a cat in which clinical and radiographic findings of a mandibular swelling were suggestive of an aggressive process, but the oral mucosa was unaffected. The results of histopathological and immunohistochemical examination of the samples obtained from the intraosseous lesion were consistent with SCC. The animal was euthanized 5 months after initial presentation as a result of the severe progression of the disease, and no other primary tumors were identified at necropsy. Conclusions Based on the clinicopathological, microscopic, and immunohistochemical staining features, as well as the absence of a primary tumor at a distant site, we propose that the term, solid type primary intraosseous SCC (PIOSCC), be used to describe this neoplasia, as it shares similar features with human PIOSCC.
Collapse
Affiliation(s)
- Darja Pavlin
- University of Ljubljana, Veterinary faculty, Small Animal Clinic, Gerbičeva, 60, Ljubljana, Slovenia.
| | - Tamara Dolenšek
- University of Ljubljana, Veterinary faculty, Institute of Pathology, Wild Animals, Fish and Bees, Gerbičeva, 60, Ljubljana, Slovenia
| | - Tanja Švara
- University of Ljubljana, Veterinary faculty, Institute of Pathology, Wild Animals, Fish and Bees, Gerbičeva, 60, Ljubljana, Slovenia
| | - Ana Nemec
- University of Ljubljana, Veterinary faculty, Small Animal Clinic, Gerbičeva, 60, Ljubljana, Slovenia
| |
Collapse
|
3
|
Ray AC, Foletti JM, Graillon N, Guyot L, Chossegros C. [De novo (type 3) primary intraosseous carcinoma of the jaws]. ACTA ACUST UNITED AC 2016; 117:411-420. [PMID: 27527660 DOI: 10.1016/j.revsto.2016.07.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2016] [Accepted: 07/07/2016] [Indexed: 11/15/2022]
Abstract
INTRODUCTION Primary intraosseous carcinoma (PIOC) of the jaws is a rare epidermoid carcinoma from epithelial origin and initially strictly localized within the bone. Histologically, type 3 PIOC (PIOC3) is a de novo primary intraosseous carcinoma. Because of the rarity of this illness, we propose an analysis of a personal case and a revue of the literature. MATERIAL AND METHODS Two search engines (Pubmed®, Sciencedirect®) were questioned over the period 1976-February 2016 by using following keywords carcinoma, intraosseous, jaws, squamous cell carcinoma. Articles reporting proven PIOC3 and mentioning a precise treatment were selected. RESULTS Thirty articles concerning 54 patients (sex ratio: 2.4; mean age: 56.8; extreme: 24-78) met the inclusion criterions. The most common symptoms were swelling (53%), pain (44.9%) and infra-alveolar nerve paresthesia (30.6%). The time to diagnosis was 13 weeks. Classification of Zwetyenga et al. showed more than 80% of T2 and T3 stages. The lesions were predominantly mandibular (85.2%) and posterior. Less than a third of patients had lymph node and 10% had distant metastasis. Treatment consisted mostly in a combination of surgery and radiotherapy. With a mean follow-up of 74.8 months, 70.8% were in remission with no evidence of recurrence. We report the case of a 58-year-old patient, with no medical history, complaining since several months about periodontitis with teeth mobility in the right mandibular area. The panoramic X-ray showed a bone lysis at the place of tooth No. 46. In the absence of alveolar healing after extraction and antibiotherapy, a biopsy was made that diagnosed a differentiated keratinizing squamous cell carcinoma. CT scan and MRI showed a mandibular cortical bone loss with involvement of adjacent structures and lymphadenopathy in the ipsilateral IB area. The patient was treated with a combination of chemotherapy and surgery. Postoperative chemo- and radiotherapy is still going on. DISCUSSION The PIOC3 is a rare tumor, mainly arising in males around 50. Diagnosis should be evoked in the presence of painful swelling and nervous symptoms. The time to diagnosis is long. Tumors are usually seen at late stages. Treatment classically combines surgery and radiotherapy.
Collapse
Affiliation(s)
- A C Ray
- Service de chirurgie maxillo-faciale, hôpital de la Conception, 147, boulevard Baille, 13385 Marseille, France; Aix-Marseille université, jardin du Pharo, 58, boulevard Charles-Livon, 13284 Marseille cedex 07, France; UMR 6057, laboratoire parole et langage (LPL), 13604 Aix-en-Provence, France.
| | - J M Foletti
- Service de chirurgie maxillo-faciale, hôpital Nord, chemin des Bourrely, 13015 Marseille, France; Aix-Marseille université, jardin du Pharo, 58, boulevard Charles-Livon, 13284 Marseille cedex 07, France; Aix-Marseille université, IFSTTAR, LBA UMR_T 24, 13916 Marseille, France
| | - N Graillon
- Service de chirurgie maxillo-faciale, hôpital de la Conception, 147, boulevard Baille, 13385 Marseille, France; Aix-Marseille université, jardin du Pharo, 58, boulevard Charles-Livon, 13284 Marseille cedex 07, France
| | - L Guyot
- Service de chirurgie maxillo-faciale, hôpital Nord, chemin des Bourrely, 13015 Marseille, France; Aix-Marseille université, jardin du Pharo, 58, boulevard Charles-Livon, 13284 Marseille cedex 07, France
| | - C Chossegros
- Service de chirurgie maxillo-faciale, hôpital de la Conception, 147, boulevard Baille, 13385 Marseille, France; Aix-Marseille université, jardin du Pharo, 58, boulevard Charles-Livon, 13284 Marseille cedex 07, France; UMR 6057, laboratoire parole et langage (LPL), 13604 Aix-en-Provence, France
| |
Collapse
|